Diagnosis of Chemotherapy-Induced Cardiotoxicity

Journal of Patient-Centered Research and Reviews

Rubina Qamar¹  Charles A. Bomzer¹  Bijoy K. Khandheria²  Fausto Pizzino³  Concetta Zito³  Giampiero Vizzari³  Scipione Carerj³ 

[1] Aurora Cancer Care, Aurora Health Care, Milwaukee, WI;Aurora Cardiovascular Services, Aurora Health Care, Milwaukee, WI;University of Messina, Messina, Italy;

关键词: cardiotoxicity;    chemotherapy side effects;    imaging method;    cardiac biomarkers;   

DOI  :  10.17294/2330-0698.1025

来源: DOAJ

【 摘 要 】

Cardiotoxicity is a rising issue connected to use of chemotherapy and radiotherapy in the treatment of neoplastic diseases. Early diagnosis during follow-up is of paramount importance, and careful surveillance is recommended. Evaluation of left ventricular ejection fraction by echocardiography and nuclear medicine techniques is widely used in clinical practice; however, their sensitivity in detecting early cardiac damage is low. New instruments like speckle-tracking imaging, cardiac magnetic resonance and cardiac circulating biomarkers are available to clinicians to best evaluate the onset and progression of cardiotoxic effects, improving the therapeutic management and final outcome for the patient.

【 授权许可】

Unknown